NCT04763083 2023-07-07First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ MalignanciesNovalGen Ltd.Phase 1 Unknown90 enrolled
NCT03544723 2020-06-09Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.MultiVir, Inc.Phase 2 Unknown40 enrolled
NCT03638206 2019-12-11Autologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesShenzhen BinDeBio Ltd.Phase 1/2 Unknown73 enrolled
NCT00757614 2013-08-26Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomNational Cancer Institute (NCI)Unknown14,000 enrolled